FTC Sees Red Flags In Studies Conducted Overseas To Support Claims
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission is wary of studies conducted overseas used to substantiate claims for supplements, says Richard Cleland, assistant director of advertising practices.
You may also be interested in...
Planned Claims Should Guide Product Development – FTC’s Cleland
The first issue a firm should consider when formulating a dietary supplement is how to support the claims it intends to make, says Federal Trade Commission official Richard Cleland.
Planned Claims Should Guide Product Development – FTC’s Cleland
The first issue a firm should consider when formulating a dietary supplement is how to support the claims it intends to make, says Federal Trade Commission official Richard Cleland.
Planned Claims Should Guide Product Development – FTC’s Cleland
The first issue a firm should consider when formulating a dietary supplement is how to support the claims it intends to make, says Federal Trade Commission official Richard Cleland.